Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06LQF
|
|||
| Drug Name |
131-I-MIP-1095
|
|||
| Synonyms |
MIP-1095 I-131; LFEGKCKGGNXWDV-LUOJOMRDSA-N; UNII-7DM27RQ9V0; 7DM27RQ9V0; Iodine I-131 MIP-1095; Iodine I 131 MIP-1095; 131I-MIP-1095; (131)I-MIP-1095; L-Glutamic acid, N-((((1S)-1-carboxy-5-((((4-(iodo-131I)phenyl)amino)carbonyl)amino)pentyl)amino)carbonyl)-; 1258980-67-4
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Phase 1 | [1], [2] | |
| Company |
Progenics Pharmaceuticals New York, NY
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H25IN4O8
|
|||
| Canonical SMILES |
C1=CC(=CC=C1NC(=O)NCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O)I
|
|||
| InChI |
1S/C19H25IN4O8/c20-11-4-6-12(7-5-11)22-18(31)21-10-2-1-3-13(16(27)28)23-19(32)24-14(17(29)30)8-9-15(25)26/h4-7,13-14H,1-3,8-10H2,(H,25,26)(H,27,28)(H,29,30)(H2,21,22,31)(H2,23,24,32)/t13-,14-/m0/s1/i20+4
|
|||
| InChIKey |
LFEGKCKGGNXWDV-LUOJOMRDSA-N
|
|||
| CAS Number |
CAS 1258980-67-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.